Lexology November 11, 2025
AlixPartners

Private equity’s investments in healthcare have often struggled to meet expectations. Top-line growth and attractive exit multiples are elusive in a sector weighed down by legacy systems, labor costs, and regulatory complexity. The urgent question facing investors, operating partners, and portfolio company leaders is: How can we reinvigorate returns and unlock enterprise value?

In this article, we will explore how AI is already making an impact in specific use cases in HealthTech and tech-enabled services.

The AI moment for HealthTech

Our data show a clear gap in HealthTech company performance, especially for the PE owned mature mid-tier ones: despite double-digit revenue growth in HealthTech (26.7%) over the past 3 years, EBITDA margins lag well behind other industry segments. For most...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Digital Health, Health IT, Investments, Mergers & Acquisitions / JV, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article